COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the fourth quarter and full year ended December 31, 2024, and provided a ...
COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its Board of Directors has authorized the Company to use approximately $25 million to ...
Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.
16h
Wrestlezone on MSNAJ Styles Clarifies Who Owns His P1 LogoAJ Styles has made it clear who owns his iconic P1 logo. The former WWE Champion has used the logo for years, even before ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Edwards Lifesciences (EW – Research Report), Arrowhead ...
We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...
As a market leader, Rocket Companies rebranding comes in the foreground of several court battles and fluctuating earnings ...
Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...
Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...
Robert F. Kennedy Jr’s message of eliminating toxins and investigating public health agencies has resonated among a key group ...
Morgan Stanley analyst Jeffrey Hung maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results